These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 2181734)

  • 1. [Silent HIV infection in HIV seronegative individuals?].
    Waldum HL; Iversen OJ
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):997-8. PubMed ID: 2181734
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and titer of anti-rev antibody in HIV infection.
    Dairaku M; Tsuchie H; Ushijima H; Aoki I; Okuda K; Honda M; Ikegami N; Hachimori K; Matsuda J; Kitamura T
    AIDS; 1989 Nov; 3(11):765-6. PubMed ID: 2515884
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men: a report from the Multicenter AIDS Cohort Study.
    Dis Markers; 1989; 7(4):257-8. PubMed ID: 2684476
    [No Abstract]   [Full Text] [Related]  

  • 4. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
    Björling E; Scarlatti G; von Gegerfelt A; Albert J; Biberfeld G; Chiodi F; Norrby E; Fenyö EM
    Virology; 1993 Mar; 193(1):528-30. PubMed ID: 8438591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data.
    MacGregor RR; Boyer JD; Ciccarelli RB; Ginsberg RS; Weiner DB
    J Infect Dis; 2000 Jan; 181(1):406. PubMed ID: 10608800
    [No Abstract]   [Full Text] [Related]  

  • 6. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
    Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
    Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A seronegative case of HIV-1 subtype C infection in Botswana.
    Novitsky V; Gaolathe T; Woldegabriel E; Makhema J; Essex M
    Clin Infect Dis; 2007 Sep; 45(5):e68-71. PubMed ID: 17682982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three cases of transient HIV-1 seropositivity observed in 10 years of practice of a national HIV confirmatory laboratory.
    Tarján V; Ujhelyi E; Kellner R; Králl G; Gyuris A; Mihály I; Füst G
    AIDS; 1998 Jan; 12(1):120-1. PubMed ID: 9456268
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of anti-p27nef antibody detection in HIV-seronegative high-risk people.
    Gluckman JC; Fretz-Foucault C; Rouzioux C; Perret P; Lopez O; Bucquet D; Bahraoui E
    AIDS; 1989 Dec; 3(12):855-6. PubMed ID: 2517205
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
    Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
    Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary infection by human immunodeficiency virus].
    Picard C; Oberlin P; Lazareth I; Crickx B; Belaïch S
    Ann Dermatol Venereol; 1990; 117(11):861-4. PubMed ID: 2099708
    [No Abstract]   [Full Text] [Related]  

  • 13. Median incubation time for human immunodeficiency virus (HIV).
    Winkelstein W; Royce RA; Sheppard HW
    Ann Intern Med; 1990 May; 112(10):797-8. PubMed ID: 2331124
    [No Abstract]   [Full Text] [Related]  

  • 14. MDSC: a new player in HIV immunopathogenesis.
    Macatangay BJ; Landay AL; Rinaldo CR
    AIDS; 2012 Jul; 26(12):1567-9. PubMed ID: 22810370
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunodeficiency.
    Curr Opin Immunol; 1992 Aug; 4(4):523-43. PubMed ID: 1388851
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of the response to HIV-1 needs a combined approach.
    Morris K
    Lancet; 1997 Oct; 350(9083):1009. PubMed ID: 9329525
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-1 infection and eosinophilia.
    Caterino-de-Araujo A
    Immunol Today; 1994 Oct; 15(10):498-9. PubMed ID: 7945779
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of anti-HIV antibodies at the autopsy table].
    Hernández Cordero E; Bedate Gutiérrez A; Molina Bayón M; Perea Folgueras M; Segura Abad L; Abenja Roso JM; Muñoz Rey L
    Rev Clin Esp; 1992 Apr; 190(7):376-7. PubMed ID: 1620929
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to the letter to the editor: antibody-mediated control of HIV-1 through an alternative pathway.
    Green JA; Lum T
    AIDS; 2020 Mar; 34(4):645. PubMed ID: 32108674
    [No Abstract]   [Full Text] [Related]  

  • 20. The "basics" of HIV-1 assembly.
    Sumner C; Ono A
    PLoS Pathog; 2024 Feb; 20(2):e1011937. PubMed ID: 38300900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.